Clinical Efficacy and Safety of Eravacycline for the Treatment of Enterococcal Infections: A Subpopulation Analysis

Authors

• S. R. Van Helden
• A. J. Kunz Coyne
• S. Alosaimy
• K. C. Molina
• S. Lena Kang-Birken
• Justin Andrade, Touro College of PharmacyFollow
• M. A. King
• K. C. Claeys
• A. L. V. Hobbs
• N. B. Perkins III
• J. Agee
• A. DeKerlegand
• M. Biagi
• M. P. Veve
• S. Tart
• T. Gore
• B. M. Jones
• B. M. Pullinger
• M. R. Schrack
• R. Cosimi
• S. R. Herbin
• C. Judd
• M. A. Musawa
• M. J. Rybak

Roles

Author

Document Type

Article

Publication Date

1-1-2025

Publication Title

BMC Infectious Diseases

DOI

10.1186/s12879-025-11982-4

Recommended Citation

Van Helden, S. R., Kunz Coyne, A. J., Alosaimy, S., Molina, K. C., Lena Kang-Birken, S., Andrade, J., King, M. A., Claeys, K. C., Hobbs, A. L., Perkins III, N. B., Agee, J., DeKerlegand, A., Biagi, M., Veve, M. P., Tart, S., Gore, T., Jones, B. M., Pullinger, B. M., Schrack, M. R., Cosimi, R., Herbin, S. R., Judd, C., Musawa, M. A., & Rybak, M. J. (2025). Clinical Efficacy and Safety of Eravacycline for the Treatment of Enterococcal Infections: A Subpopulation Analysis. BMC Infectious Diseases, 25 (1), Article 1754. https://doi.org/10.1186/s12879-025-11982-4